{"name":"Lykos Therapeutics","slug":"lykos-therapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxNbEV1R2toOHdnWUk2ZHFRV2V2ekREd1dzS1VqVU5nb0dmb3NRWWhfOXpqQkNpbVoyV2Rodk1XZ2ZlTHJtYVlUWTN6QmZreno1NGdZQmRSZnZucUlQUHBrdVdVelZURUl6MFlrTHluSWNzdmJOSlROYjNjSUFhTmhjZTE5X0dFZmoxeXlHd19EX1laYm1i?oc=5","date":"2026-01-02","type":"pipeline","source":"Psychedelic Alpha","summary":"2025 Year in Review: 10 Standout Stories in Psychedelics - Psychedelic Alpha","headline":"2025 Year in Review: 10 Standout Stories in Psychedelics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxOTFVtZmpqdzI4U3VnMzVFd3ctbWFVZ2hNUG82RW54YVlsYnZYcHJULUppVGNfZ3REQ091R3VlRDg3QnYtZWRtZTREMTRhRmczdzRKcXg4V05xZGNfZGEta2czLTBWQWEtRVNsY19YdU9yNlJ5X1ZleW9jLW14dEhiLXVTektRM25jckhpbVQtRkc4Ynli?oc=5","date":"2025-10-30","type":"regulatory","source":"statnews.com","summary":"FDA criticism of MDMA-assisted therapy is an opportunity for psychedelic medicine - statnews.com","headline":"FDA criticism of MDMA-assisted therapy is an opportunity for psychedelic medicine","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxOQlJ5S1hGb2NXTzd3akNQYlZEYy13WEdNUGV0NElwTENTOUtYV0Vub1ZKLVlmSkREa0pkcWg5YkdkTENMbkFQTk9wSXhxQzZzVEswV3Bxdzh1ZERkU0g1cTBIQk9zb2pvbmlTUmZsd0JTRzE2OVBOdUpDTXprNllQOHZKa1FIdnJPLWVDdHZkUkI3VXZRR3dXd2Fn?oc=5","date":"2025-09-22","type":"pipeline","source":"BioSpace","summary":"Psychedelics Space Enters New Era as AbbVie Dives In - BioSpace","headline":"Psychedelics Space Enters New Era as AbbVie Dives In","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxQUzE0cW12bFRZaVhVYWJnTzd3R2N0dGh5dWZfY2xoaUZSdElsN3I3TnNwSWJhNENsc1gyZVRSdnZLYUpla0FQYjhDd1RWaHhobFFQRldtTnhveGlYY0g0SVg3QkxCM09RaW1PWUQtdGxJM0xIbFBCeUFYT2ZDOWx0TURDbEJ6YVVPQ1owdzVfdHZSUlR4SmFZ?oc=5","date":"2025-09-09","type":"pipeline","source":"Politico","summary":"Lykos’ rejection letter - Politico","headline":"Lykos’ rejection letter","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiW0FVX3lxTE91cnpUcXp1am5CbkNlOEJYWUVQb1U0NEFRNHItVUtnMlZQYWotMmRUOGZMZnEyaGdWeFJQbVRtT19MM0twMHBZeVNEc2lnWl9YTHNiTkpuVXJLcWs?oc=5","date":"2025-09-08","type":"regulatory","source":"Labiotech.eu","summary":"With Lykos CRL now public, FDA opens new era of accountability - Labiotech.eu","headline":"With Lykos CRL now public, FDA opens new era of accountability","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxQYTVlN0d6NzB1M1g5N2hlUks0Yk16RGRUd21TZTkyVjBoc095Z0pZV09zaE1QNDRuZTEtZkoxWjhrTW9PdUNNU28wSV9yam1mTjljTTlDV1lxX0RRN1ZXckFyYkQzSl9BNEVBVGl1R1h2Ymg4THloZU9mQnE0RjdlMG0zQ196T2IwREVQeUtRZmhDYUZiUjZMTlU1T0kxc3ZjZVllb202YkZvY29Od3ZBSUVNQlA3UTNHZ0JaVXR6dmEydw?oc=5","date":"2025-09-05","type":"pipeline","source":"BioSpace","summary":"With Lykos MDMA Rejection Letter Out, MAPS Founder Decries ‘Change of the Goal Posts’ - BioSpace","headline":"With Lykos MDMA Rejection Letter Out, MAPS Founder Decries ‘Change of the Goal Posts’","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxOZHRsazkyS0JNOFlrbU1kTHBZYkxkZlR6Y05vMlFwRGZYVHdFR1RoM1ppc0dRd0ZaWFZ5YmU5Vi03Mi03cE5aWHlPc1R0aDNmUmZJZXFyQ3pmWmszUkpremFMNWljNTdmQVZWLWlhbU5JM3hfT3ZJOWstUVFjamlBWTIxZUdYUUd4WFNQNWttNVlJcXVCbGhNRmNFaC1KR05NQXZlQXNWMmZ5SzBTVUR0VTJIUzBiOVMxNWZF?oc=5","date":"2025-09-05","type":"regulatory","source":"Psychiatric Times","summary":"FDA Releases Complete Response Letter on Declining MDMA-Assisted Therapy for PTSD - Psychiatric Times","headline":"FDA Releases Complete Response Letter on Declining MDMA-Assisted Therapy for PTSD","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxNSnluVHU4Znp2MXRyZ2dXUDFUcXh4VTB2aXNsdzZsVHYwN2poQXZmVHc2TjNtT2xVYWRRQnZJTDlXMXFqV0FuR1NCbUVHUzE3NFFXenBVOS1abklsTDFfLWpITUhFT1FsUnoxN0toazNBYjZ3ano3V2ZJbFU3Z1JXS3VQNmtidkNZWjRBM3dLeGtKcTZEYWdzdDEyQmk5SURBR0pOcDB1bDc?oc=5","date":"2025-09-05","type":"regulatory","source":"Fierce Biotech","summary":"'Several concerning observations': FDA sheds more light on reasons it rejected drugs - Fierce Biotech","headline":"'Several concerning observations': FDA sheds more light on reasons it rejected drugs","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMiYkFVX3lxTFBEWDNVRkM4YVV4T0dGRDJKeFpaZE40SmxYbm9RcXpwZGxSdzdteEoxLU9TZ3ozcGNiRzZNVEozR2w3bURTTEtnczRtbWF5OUx4N01wdWFwNmNXLW9xUmhQbDlR?oc=5","date":"2025-08-30","type":"pipeline","source":"futurism.com","summary":"Top Elon Musk Acolyte Running Large MDMA Empire - futurism.com","headline":"Top Elon Musk Acolyte Running Large MDMA Empire","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxPVFdYV0lEV2llTDdIY3Qzdk1uRFVPZUtvbFItVFItVUdnaHhuNlFoNExJbnRMeXN1MS1UamNJbENNQ0dDbndWR3hvQ2FINHdTVTBHNTJodXEwZGw1Szg1aWJIalVkTW9oaktwUi1rUmozenVSV2lOM1FXMjhxdGZGY1NrZXM4YU5QWWN4UUJ2R1htVWxWbGROOVRhU3hQcndYUE1HYzNEZzNKN2ZsRXdr?oc=5","date":"2025-05-28","type":"trial","source":"Clinical Trials Arena","summary":"Psychedelic drug developers redesign trials to avoid Lykos faux pas - Clinical Trials Arena","headline":"Psychedelic drug developers redesign trials to avoid Lykos faux pas","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxORy10UW80Mi1wNl9GbjJKVHQ3dUpfZ2R6TDMxaWJqQ0hzMjdBUjNuUDRKelNuQUtqQTVjczZWU0E2eDVaa1J3eHI4MFNoMWhUd04xZF9NLVRTMVRaM1JVOFJKNWxzT1F6bGZkbkdnZU1IR0VCeUVLM2xCMWFWSFFnaG16c1JrQVc0Nkt5c1lRSnNJcjhmbDljZ0dsMWRsSUpnZnc?oc=5","date":"2025-04-18","type":"pipeline","source":"Pharma Voice","summary":"A big moment is coming for psychedelics - Pharma Voice","headline":"A big moment is coming for psychedelics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxOcVJnYjQtbjRmOVd6S3hvUGNzWmhOUVBuVXJaQVFDYno1Q1ZfWEZCbVQwR3RIUzkyTV9zN3FNSmt4YUR5MWcxTktDSVVablEtSnBHUGE0djJuamM5dFBIUndoYmg4T1RCMUxReVFzQVFNcmwzaXhxeVN4WlItMkZJNm9PUW8tTnF3QnZHWVJUajdtUTBFTk4ydEQtVUJaeGQxcWJoTDZIbFNaUzd2LUpIQ1dB?oc=5","date":"2024-09-16","type":"pipeline","source":"Pharmaceutical Technology","summary":"After the Lykos debacle, what’s next for psychedelic therapies? - Pharmaceutical Technology","headline":"After the Lykos debacle, what’s next for psychedelic therapies?","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}